The findings indicate that Mettl1 enhances the stability of SRSF9 through m7G modification, resulting in the upregulation of NFACT4 expression and the promotion of cardiac hypertrophy and heart failure progression. This evidence concerns the gene METTL1 and cardiac hypertrophy.